Ohio State’s novel DHODH inhibitor enters first human trials

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient’s bedside as part of a clinical trial.

RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED – Biotech Investments

Biophytis / Key word(s): Miscellaneous Biophytis: RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED

June 18, 2023

Enhancing mRNA drug development: how to optimise your suppliers and materials – Pharmaceutical Technology

Pharma companies seeking to commercialise mRNA should consider partnering with an expert material supplier today. In the wake of the Covid-19 vaccine, mRNA research and

August 21, 2024

Penn Gaming PENN stock analysis

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.